NovalGen Ltd was incorporated in October 2018 and is registered as an active private limited company at Argyle House in Northwood Hills. Its registered SIC code places it in research and experimental development on biotechnology, meaning its core activity is likely laboratory-based R&D rather than manufacturing or sales. Given the early-stage incorporation date and the modest office address, the company probably operates as a small biotech startup or a research-focused subsidiary, possibly engaged in areas such as drug discovery, molecular biology, or therapeutic development. No specific product or pipeline information is available from the structured data, so the exact specialisation remains unclear. The company holds a Skilled Worker sponsor licence with an A rating, which indicates that it is currently approved to sponsor overseas workers for skilled roles in the UK. An A rating means the company has met the Home Office requirements for sponsorship and is in good standing. Because the licence is active, NovalGen is likely actively hiring or planning to hire international talent to fill research roles such as scientists, lab technicians, or postdoctoral researchers. The small size of the company suggests that each hire may have a significant impact on its operations. International presence cannot be confirmed from the available data; the address and licence suggest a UK-only operation at this point, but this is not a definitive fact. The combination of an active sponsor licence and a niche scientific focus makes it a plausible employer for visa applicants with biotechnology backgrounds.

NovalGen Ltd was incorporated in October 2018 and is registered as an active private limited company at Argyle House in Northwood Hills. Its registered SIC code places it in research and experimental development on biotechnology, meaning its core activity is likely laboratory-based R&D rather than manufacturing or sales. Given the early-stage incorporation date and the modest office address, the company probably operates as a small biotech startup or a research-focused subsidiary, possibly engaged in areas such as drug discovery, molecular biology, or therapeutic development. No specific product or pipeline information is available from the structured data, so the exact specialisation remains unclear. The company holds a Skilled Worker sponsor licence with an A rating, which indicates that it is currently approved to sponsor overseas workers for skilled roles in the UK. An A rating means the company has met the Home Office requirements for sponsorship and is in good standing. Because the licence is active, NovalGen is likely actively hiring or planning to hire international talent to fill research roles such as scientists, lab technicians, or postdoctoral researchers. The small size of the company suggests that each hire may have a significant impact on its operations. International presence cannot be confirmed from the available data; the address and licence suggest a UK-only operation at this point, but this is not a definitive fact. The combination of an active sponsor licence and a niche scientific focus makes it a plausible employer for visa applicants with biotechnology backgrounds.